American Healthcare REIT raises 2026 growth outlook

The stock has already moved like the market is starting to believe the story. American Healthcare REIT closed at $59.39 on Nov. 10, up sharply from the high-$40s in early October, and now sits above both its 50-day and 200-day moving averages. The shares’ 75.3 RSI reading points to a stretched near-term setup, but the broader message is that momentum is being backed by fundamentals, not just a short squeeze or a defensive bid.

The earnings backdrop is also pulling the entire healthcare REIT complex into focus. CareTrust REIT’s own filing the same day underscored how active capital is flowing into care-home platforms, while Omega Healthcare Investors’ £615 million acquisition shows that larger players still see room to expand. That kind of deal activity matters because it supports asset values, improves financing optionality and reinforces the view that senior housing remains one of the more attractive corners of the property market.

American Healthcare’s latest filing also points to a company still using equity markets to fund growth, with liquidity tied in part to ATM issuance. That is a two-sided fact for shareholders: dilution is never free, but in a sector where asset prices and operating cash flow are rising together, access to cheap capital can be a competitive weapon rather than a drag.

The market is underestimating how powerful that combination can be if demographic demand keeps compounding. An aging population, tighter healthcare labor supply and a constrained pipeline of high-quality senior housing assets create a secular tailwind that should favor the best-capitalized operators first. If AHR can sustain this operating beat, the next leg is likely to come not from multiple expansion alone, but from a longer runway of NOI growth, accretive capital deployment and dividend durability. For investors looking for exposure to the healthcare real estate inflection point, AHR is one of the names to watch closely now.